Cargando…
Clinical impact of genetic alterations of CTNNB1 in patients with grade 3 endometrial endometrioid carcinoma
To identify prognostic factors in patients with grade 3 (high‐grade) endometrial endometrioid carcinoma, we evaluated the spectrum of genomic alterations and examined whether previously reported molecular subtypes of endometrial carcinoma were adapted to clinical outcome prediction. Seventy‐five Jap...
Autores principales: | Kobayashi Kato, Mayumi, Asami, Yuka, Takayanagi, Daisuke, Matsuda, Maiko, Shimada, Yoko, Hiranuma, Kengo, Kuno, Ikumi, Komatsu, Masaaki, Hamamoto, Ryuji, Matsumoto, Koji, Ishikawa, Mitsuya, Kohno, Takashi, Kato, Tomoyasu, Shiraishi, Kouya, Yoshida, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128156/ https://www.ncbi.nlm.nih.gov/pubmed/35278272 http://dx.doi.org/10.1111/cas.15328 |
Ejemplares similares
-
Predictive model for the preoperative assessment and prognostic modeling of lymph node metastasis in endometrial cancer
por: Asami, Yuka, et al.
Publicado: (2022) -
Comparative Analysis of Genetic Alterations, HPV-Status, and PD-L1 Expression in Neuroendocrine Carcinomas of the Cervix
por: Takayanagi, Daisuke, et al.
Publicado: (2021) -
TP53 mutants and non-HPV16/18 genotypes are poor prognostic factors for concurrent chemoradiotherapy in locally advanced cervical cancer
por: Kuno, Ikumi, et al.
Publicado: (2021) -
Rare FGFR fusion genes in cervical cancer and transcriptome‐based subgrouping of patients with a poor prognosis
por: Hiranuma, Kengo, et al.
Publicado: (2023) -
Utility of molecular subtypes and genetic alterations for evaluating clinical outcomes in 1029 patients with endometrial cancer
por: Asami, Yuka, et al.
Publicado: (2023)